RPAM
JUNO

Rhenman & Partners Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-109,430
Closed -$5M – 102
2017
Q4 		$5M Buy
109,430
+9,430
+9% +$431K 0.68% 54
2017
Q3 		$4.49M Buy
+100,000
New +$4.49M 0.57% 62